Vascular dysplasia in neurofibromatosis type 2

Neurology

Volumn 65, Issue 1, 2005, Pages 163-164

  Ryan, Aisling M ^a   Hurley, Michael ^a   Brennan, Paul ^a   Moroney, Joan T ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CEREBRAL ARTERY DISEASE; EPILEPSY; FEMALE; HUMAN; MORBIDITY; MORTALITY; NEURILEMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCOLIOSIS; VASCULAR DISEASE;

EID: 22044440484     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000167134.04302.17     Document Type: Article

References (7)

1. Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004;17:101-105.
2. Hamilton SJ, Friedman JM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 2000;58:341-344.
3. Baser ME, Evans DG, Gutmann DH. Neurofibromatosis 2. Curr Opin Neurol 2003;16:27-33.
4. Evans DG, Trueman L, Wallace A, Collins S, Strachan T. Genotype/ phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 1998;35:450-455.
5. Lesley WS, Thomas MR, Abdulrauf SI. N-butylcyanoacrylate embolization of a middle meningeal artery aneurysm in a patient with neurofibromatosis type 2. Am J Neuroradiol 2004;25:1414-1416.
6. Baser ME, Kuramoto L, Joe H, et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. Am J Hum Genet 2004;75:231-239.
7. Ramesh V. Merlin and the ERM proteins in Schwann cells, neurons and growth cones. Nat Rev Neurosci 2004;5:462-470.